In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Frontiers in CardioVascular Biomedicine 2024

12/04/2024 00:00 14/04/2024 00:00 Europe/Paris Frontiers in CardioVascular Biomedicine 2024

Access event page

ESC Council on Basic Cardiovascular Science contact@escardio.org true DD/MM/YYYY
Basic Science
In-person
event

Summary

The Frontiers in CardioVascular Biomedicine meeting is the place where all professionals from basic and translational cardiovascular biology come together.

Important deadlines

It was great seeing so many of you at the Frontiers in CardioVascular Biomedicine (FCVB) 2024 in Amsterdam.

We hope you found it as enriching as we did and that you enjoyed connecting with other cardiovascular scientists.

All the presentations and abstracts will be available to delegates on the congress platform until 9 May.

Become a member of the ESC Council on Basic Cardiovascular Science for year-long access to these resources on ESC 365, the cardiology knowledge hub.   

We look forward to welcoming you in Leuven, Belgium,  for the 2026 edition of FCVB, from 17 to 19 April.

The Frontiers in CardioVascular Biomedicine is the place where basic and translational cardiovascular biomedicine professionals come together.

The ESC Council on Basic Cardiovascular Science, ESC working groups and sister societies are collaborating to showcase the very latest science while highlighting the connections between new areas of research.

It brings a unique scientific programme and time to discuss the latest findings and ideas with clinicians and researchers, working alongside experts in the field, with the aim to promote the dissemination of knowledge and improve patient outcomes.